U S Department of Health and Human Services www.hhs.gov
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > Indexes Home > Technology Assessments > View Technology Assessment

Medicare Coverage Database

Technology Assessments


 Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes
Issue

Diabetes mellitus is a chronic condition associated with abnormally high levels of glucose in the blood whereas the body does not produce enough insulin or the insulin that is produced is ineffective. The blood sugar level may be monitored by the patient at various frequencies.  The high blood glucose levels can sometimes be controlled with diet and exercise alone but may also require the use of insulin or other medications. The main goal of diabetes management is to control blood glucose levels and thereby to prevent the complications of diabetes. Diabetes when not well controlled is a leading cause of adult blindness, lower-limb amputation and kidney disease. The hemoglobin A1C test is a blood test that measures average blood glucose control over a three-month period that helps to identify longer-term trends in glucose levels and where adjustments in treatment are needed.

Technology Assessment

Download Technology Assessment [PDF, 2MB].


basket Add to basket  |  envelope icon - email Email this to a friend  |  new search New Search



Page Last Modified: 11/18/2008 12:01:34 PM

Help with File Formats and Plug-Ins

Submit Feedback





www1